Merger Review Guidance

Prescription Drugs and Private Equity

FTC Challenges Patents as Improperly Listed in FDA Orange Book

FTC Activity

FTC and Health Data

FTC Pharmacy Benefit Manager Investigation

Provider Antitrust Guidance Rescinded

FTC Non-Competes